Market Research Logo

Respiratory Tract Infections Drug Development Pipeline Review, 2018

Respiratory Tract Infections Drug Development Pipeline Review, 2018

Summary


Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph nodes and bloodstream to any organ in the body. It is most often found in the lungs. The symptoms of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease. Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus, fatigue, shortness of breath, weight loss and pain in the chest. There are 206 products in development for this indication.

Diphtheria is a bacterial infection that affects the membranes of the throat and nose. If left untreated, diphtheria can cause severe damage to kidneys, nervous system, and heart. Symptoms include sore throat and hoarseness, swollen glands (enlarged lymph nodes) in neck, nasal discharge, fever and chills and malaise. Treatment includes antitoxins and antibiotics. There are 31 products in development for this indication.

Pertussis is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes and dry cough. Treatment includes antibiotics. There are 40 products in development for this indication.

Molecular targets acted on by products in development for respiratory tract infections include bacterial proteins and toxins. Companies operating in this pipeline space include Beijing Minhai Biotechnology, Sanofi and GlaxoSmithKline.

This report “Respiratory Tract Infections Drug Development Pipeline Review, 2018”provides an overview of the pipeline landscape for respiratory tract infections. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for tuberculosis, diphtheria and pertussis (whooping cough), and features dormant and discontinued products.

Scope

  • Which companies are the most active within each pipeline?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration


  • GBI Research Report Guidance
  • Executive Summary
  • Introduction
    • Respiratory Tract Infections Report Coverage
    • Tuberculosis – Overview
    • Diphtheria – Overview
    • Pertussis (Whooping Cough) – Overview
  • Therapeutics Development
    • Tuberculosis
      • Pipeline Overview
        • Table Figure 1: Number of Products under Development for Tuberculosis
        • Table Number of Products under Development for Tuberculosis
      • Pipeline by Companies
        • Table Figure 2: Number of Products under Development by Companies Tuberculosis
        • Table Number of Products under Development by Companies Tuberculosis
      • Pipeline by Universities/Institutes
        • Table Figure 3: Number of Products under Development by Universities/Institutes Tuberculosis
        • Table Number of Products under Development by Universities/Institutes Tuberculosis
      • Products under Development by Companies
        • Table Products under Development by Companies Tuberculosis
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes Tuberculosis
    • Diphtheria
      • Pipeline Overview
        • Table Figure 4: Number of Products under Development for Diphtheria
        • Table Number of Products under Development for Diphtheria
      • Pipeline by Companies
        • Table Figure 5: Number of Products under Development by Companies Diphtheria
        • Table Number of Products under Development by Companies Diphtheria
      • Pipeline by Universities/Institutes
        • Table Figure 6: Number of Products under Development by Universities/Institutes Diphtheria
        • Table Number of Products under Development by Universities/Institutes Diphtheria
      • Products under Development by Companies
        • Table Products under Development by Companies Diphtheria
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes Diphtheria
    • Pertussis (Whooping Cough)
      • Pipeline Overview
        • Table Figure 7: Number of Products under Development for Pertussis (Whooping Cough)
        • Table Number of Products under Development for Pertussis (Whooping Cough)
      • Pipeline by Companies
        • Table Figure 8: Number of Products under Development by Companies Pertussis (Whooping Cough)
        • Table Number of Products under Development by Companies Pertussis (Whooping Cough)
      • Pipeline by Universities/Institutes
        • Table Figure 9: Number of Products under Development by Universities/Institutes Pertussis (Whooping Cough)
        • Table Number of Products under Development by Universities/Institutes Pertussis (Whooping Cough)
      • Products under Development by Companies
        • Table Products under Development by Companies Pertussis (Whooping Cough)
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes Pertussis (Whooping Cough)
  • Therapeutics Assessment
    • Tuberculosis
      • Assessment by Target
        • Table Figure 10: Number of Products by Top 10 Targets Tuberculosis
        • Table Figure 11: Number of Products by Stage and Top 10 Targets Tuberculosis
        • Table Number of Products by Stage and Target Tuberculosis
      • Assessment by Mechanism of Action
        • Table Figure 12: Number of Products by Top 10 Mechanism of Actions Tuberculosis
        • Table Figure 13: Number of Products by Stage and Top 10 Mechanism of Actions Tuberculosis
        • Table Number of Products by Stage and Mechanism of Action Tuberculosis
      • Assessment by Route of Administration
        • Table Figure 14: Number of Products by Routes of Administration Tuberculosis
        • Table Figure 15: Number of Products by Stage and Routes of Administration Tuberculosis
        • Table Number of Products by Stage and Route of Administration Tuberculosis
      • Assessment by Molecule Type
        • Table Figure 16: Number of Products by Top 10 Molecule Types Tuberculosis
        • Table Figure 17: Number of Products by Stage and Top 10 Molecule Types Tuberculosis
        • Table Number of Products by Stage and Molecule Type Tuberculosis
    • Diphtheria
      • Assessment by Target
        • Table Figure 18: Number of Products by Targets Diphtheria
        • Table Figure 19: Number of Products by Stage and Targets Diphtheria
        • Table Number of Products by Stage and Target Diphtheria
      • Assessment by Route of Administration
        • Table Figure 20: Number of Products by Routes of Administration Diphtheria
        • Table Figure 21: Number of Products by Stage and Routes of Administration Diphtheria
        • Table Number of Products by Stage and Route of Administration Diphtheria
      • Assessment by Molecule Type
        • Table Figure 22: Number of Products by Molecule Types Diphtheria
        • Table Figure 23: Number of Products by Stage and Molecule Types Diphtheria
        • Table Number of Products by Stage and Molecule Type Diphtheria
    • Pertussis (Whooping Cough)
      • Assessment by Target
        • Table Figure 24: Number of Products by Targets Pertussis (Whooping Cough)
        • Table Figure 25: Number of Products by Stage and Targets Pertussis (Whooping Cough)
        • Table Number of Products by Stage and Target Pertussis (Whooping Cough)
      • Assessment by Mechanism of Action
        • Table Number of Products by Stage and Mechanism of Action Pertussis (Whooping Cough)
      • Assessment by Route of Administration
        • Table Figure 26: Number of Products by Routes of Administration Pertussis (Whooping Cough)
        • Table Figure 27: Number of Products by Stage and Routes of Administration Pertussis (Whooping Cough)
        • Table Number of Products by Stage and Route of Administration Pertussis (Whooping Cough)
      • Assessment by Molecule Type
        • Table Figure 28: Number of Products by Top 10 Molecule Types Pertussis (Whooping Cough)
        • Table Figure 29: Number of Products by Stage and Molecule Types Pertussis (Whooping Cough)
        • Table Number of Products by Stage and Molecule Type Pertussis (Whooping Cough)
  • Companies Involved in Therapeutics Development
    • Tuberculosis
      • Abera Bioscience AB
        • Table Tuberculosis – Pipeline by Abera Bioscience AB
      • AGILeBiotics BV
        • Table Tuberculosis – Pipeline by AGILeBiotics BV
      • Akshaya Bio Inc
        • Table Tuberculosis – Pipeline by Akshaya Bio Inc
      • Archivel Farma SL
        • Table Tuberculosis – Pipeline by Archivel Farma SL
      • AstraZeneca Plc
        • Table Tuberculosis – Pipeline by AstraZeneca Plc
      • Aucta Pharmaceuticals LLC
        • Table Tuberculosis – Pipeline by Aucta Pharmaceuticals LLC
      • BioLingus AG
        • Table Tuberculosis – Pipeline by BioLingus AG
      • Bioversys AG
        • Table Tuberculosis – Pipeline by Bioversys AG
      • Celgene Corp
        • Table Tuberculosis – Pipeline by Celgene Corp
      • Chongqing Zhifei Biological Products Co Ltd
        • Table Tuberculosis – Pipeline by Chongqing Zhifei Biological Products Co Ltd
      • Consegna Pharma Inc
        • Table Tuberculosis – Pipeline by Consegna Pharma Inc
      • Crestone Inc
        • Table Tuberculosis – Pipeline by Crestone Inc
      • Daiichi Sankyo Co Ltd
        • Table Tuberculosis – Pipeline by Daiichi Sankyo Co Ltd
      • Demuris Ltd
        • Table Tuberculosis – Pipeline by Demuris Ltd
      • Eisai Co Ltd
        • Table Tuberculosis – Pipeline by Eisai Co Ltd
      • Eli Lilly and Co
        • Table Tuberculosis – Pipeline by Eli Lilly and Co
      • EpiVax Inc
        • Table Tuberculosis – Pipeline by EpiVax Inc
      • Evotec AG
        • Table Tuberculosis – Pipeline by Evotec AG
      • FIT Biotech Oy
        • Table Tuberculosis – Pipeline by FIT Biotech Oy
      • GangaGen Inc
        • Table Tuberculosis – Pipeline by GangaGen Inc
      • GC Pharma
        • Table Tuberculosis – Pipeline by GC Pharma
      • GlaxoSmithKline Plc
        • Table Tuberculosis – Pipeline by GlaxoSmithKline Plc
      • Globeimmune Inc
        • Table Tuberculosis – Pipeline by Globeimmune Inc
      • Hager Biosciences LLC
        • Table Tuberculosis – Pipeline by Hager Biosciences LLC
      • Hsiri Therapeutics LLC
        • Table Tuberculosis – Pipeline by Hsiri Therapeutics LLC
      • Immodulon Therapeutics Ltd
        • Table Tuberculosis – Pipeline by Immodulon Therapeutics Ltd
      • Immunitor Inc
        • Table Tuberculosis – Pipeline by Immunitor Inc
      • ImmunoBiology Ltd
        • Table Tuberculosis – Pipeline by ImmunoBiology Ltd
      • Innovare R & D SA De CV
        • Table Tuberculosis – Pipeline by Innovare R & D SA De CV
      • Inovio Pharmaceuticals Inc
        • Table Tuberculosis – Pipeline by Inovio Pharmaceuticals Inc
      • Johnson & Johnson
        • Table Tuberculosis – Pipeline by Johnson & Johnson
      • LegoChem Biosciences Inc
        • Table Tuberculosis – Pipeline by LegoChem Biosciences Inc
      • Matinas BioPharma Holdings Inc
        • Table Tuberculosis – Pipeline by Matinas BioPharma Holdings Inc
      • Merck & Co Inc
        • Table Tuberculosis – Pipeline by Merck & Co Inc
      • Microbiotix Inc
        • Table Tuberculosis – Pipeline by Microbiotix Inc
      • Novartis AG
        • Table Tuberculosis – Pipeline by Novartis AG
      • NovoBiotic Pharmaceuticals LLC
        • Table Tuberculosis – Pipeline by NovoBiotic Pharmaceuticals LLC
      • Otsuka Holdings Co Ltd
        • Table Tuberculosis – Pipeline by Otsuka Holdings Co Ltd
      • Pfizer Inc
        • Table Tuberculosis – Pipeline by Pfizer Inc
      • QureTech Bio AB
        • Table Tuberculosis – Pipeline by QureTech Bio AB
      • Qurient Co Ltd
        • Table Tuberculosis – Pipeline by Qurient Co Ltd
      • Recce Ltd
        • Table Tuberculosis – Pipeline by Recce Ltd
      • Rodos BioTarget GmbH
        • Table Tuberculosis – Pipeline by Rodos BioTarget GmbH
      • Sanofi
        • Table Tuberculosis – Pipeline by Sanofi
      • Sanofi Pasteur SA
        • Table Tuberculosis – Pipeline by Sanofi Pasteur SA
      • Sequella Inc
        • Table Tuberculosis – Pipeline by Sequella Inc
      • Shionogi & Co Ltd
        • Table Tuberculosis – Pipeline by Shionogi & Co Ltd
      • Takeda Pharmaceutical Co Ltd
        • Table Tuberculosis – Pipeline by Takeda Pharmaceutical Co Ltd
      • Target Medicals LLC
        • Table Tuberculosis – Pipeline by Target Medicals LLC
      • Theravectys SA
        • Table Tuberculosis – Pipeline by Theravectys SA
      • TVAX Biomedical Inc
        • Table Tuberculosis – Pipeline by TVAX Biomedical Inc
      • Vaccibody AS
        • Table Tuberculosis – Pipeline by Vaccibody AS
      • Vakzine Projekt Management GmbH
        • Table Tuberculosis – Pipeline by Vakzine Projekt Management GmbH
      • Vaxil Bio Therapeutics Ltd
        • Table Tuberculosis – Pipeline by Vaxil Bio Therapeutics Ltd
      • Vaxine Pty Ltd
        • Table Tuberculosis – Pipeline by Vaxine Pty Ltd
      • Vichem Chemie Research Ltd
        • Table Tuberculosis – Pipeline by Vichem Chemie Research Ltd
    • Diphtheria
      • Beijing Minhai Biotechnology Co Ltd
        • Table Diphtheria – Pipeline by Beijing Minhai Biotechnology Co Ltd
      • Biological E Ltd
        • Table Diphtheria – Pipeline by Biological E Ltd
      • Boryung Pharmaceutical Co Ltd
        • Table Diphtheria – Pipeline by Boryung Pharmaceutical Co Ltd
      • Cadila Healthcare Ltd
        • Table Diphtheria – Pipeline by Cadila Healthcare Ltd
      • Chongqing Zhifei Biological Products Co Ltd
        • Table Diphtheria – Pipeline by Chongqing Zhifei Biological Products Co Ltd
      • GC Pharma
        • Table Diphtheria – Pipeline by GC Pharma
      • GlaxoSmithKline Plc
        • Table Diphtheria – Pipeline by GlaxoSmithKline Plc
      • Indian Immunologicals Ltd
        • Table Diphtheria – Pipeline by Indian Immunologicals Ltd
      • Kaketsuken
        • Table Diphtheria – Pipeline by Kaketsuken
      • LG Chem Ltd
        • Table Diphtheria – Pipeline by LG Chem Ltd
      • Panacea Biotec Ltd
        • Table Diphtheria – Pipeline by Panacea Biotec Ltd
      • Sanofi
        • Table Diphtheria – Pipeline by Sanofi
      • Sanofi Pasteur SA
        • Table Diphtheria – Pipeline by Sanofi Pasteur SA
      • Serum Institute of India Ltd
        • Table Diphtheria – Pipeline by Serum Institute of India Ltd
      • Shantha Biotechnics Pvt Ltd
        • Table Diphtheria – Pipeline by Shantha Biotechnics Pvt Ltd
      • Wockhardt Ltd
        • Table Diphtheria – Pipeline by Wockhardt Ltd
    • Pertussis (Whooping Cough)
      • Beijing Minhai Biotechnology Co Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Beijing Minhai Biotechnology Co Ltd
      • Bharat Biotech Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Bharat Biotech Ltd
      • Biological E Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Biological E Ltd
      • BlueWillow Biologics
        • Table Pertussis (Whooping Cough) – Pipeline by BlueWillow Biologics
      • Boryung Pharmaceutical Co Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Boryung Pharmaceutical Co Ltd
      • Cadila Healthcare Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Cadila Healthcare Ltd
      • Chongqing Zhifei Biological Products Co Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Chongqing Zhifei Biological Products Co Ltd
      • DBV Technologies SA
        • Table Pertussis (Whooping Cough) – Pipeline by DBV Technologies SA
      • GC Pharma
        • Table Pertussis (Whooping Cough) – Pipeline by GC Pharma
      • GlaxoSmithKline Plc
        • Table Pertussis (Whooping Cough) – Pipeline by GlaxoSmithKline Plc
      • Indian Immunologicals Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Indian Immunologicals Ltd
      • Kaketsuken
        • Table Pertussis (Whooping Cough) – Pipeline by Kaketsuken
      • LG Chem Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by LG Chem Ltd
      • Panacea Biotec Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Panacea Biotec Ltd
      • Sanofi
        • Table Pertussis (Whooping Cough) – Pipeline by Sanofi
      • Sanofi Pasteur SA
        • Table Pertussis (Whooping Cough) – Pipeline by Sanofi Pasteur SA
      • Serum Institute of India Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Serum Institute of India Ltd
      • Shantha Biotechnics Pvt Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Shantha Biotechnics Pvt Ltd
      • Synthetic Biologics Inc
        • Table Pertussis (Whooping Cough) – Pipeline by Synthetic Biologics Inc
      • Wockhardt Ltd
        • Table Pertussis (Whooping Cough) – Pipeline by Wockhardt Ltd
  • Dormant Projects
    • Tuberculosis
      • Table Tuberculosis – Dormant Projects
    • Diphtheria
      • Table Diphtheria – Dormant Projects
    • Pertussis (Whooping Cough)
      • Table Pertussis (Whooping Cough) – Dormant Projects
  • Discontinued Products
    • Tuberculosis
      • Table Tuberculosis – Discontinued Products
    • Diphtheria
      • Table Diphtheria – Discontinued Products
    • Pertussis (Whooping Cough)
      • Table Pertussis (Whooping Cough) – Discontinued Products
  • Product Development Milestones
    • Tuberculosis
      • Featured News & Press Releases
    • Diphtheria
      • Featured News & Press Releases
    • Pertussis (Whooping Cough)
      • Featured News & Press Releases
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report